XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

30 hedge funds and large institutions have $80.6M invested in Xenon Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 0 closing their positions.

Holders
30
Holders Change
+9
Holders Change %
+42.86%
% of All Funds
0.8%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
9
Increased
8
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
1
BVF Inc
California
$25.2M
2
O
2
OrbiMed
New York
$8.1M
3
TCM
3
Tekla Capital Management
Massachusetts
$5.67M
4
PA
4
Perceptive Advisors
New York
$6.18M
5
GTC
5
Ghost Tree Capital
New York
$2.63M

Top Sellers

1
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$2.98M
2
IPC
2
Invesco Private Capital
New York
$3.34M
3
LWIC
3
Leith Wheeler Investment Counsel
British Columbia, Canada
$171K
4
WMSA
4
Weiss Multi-Strategy Advisers
New York
$255K
5
Wells Fargo
5
Wells Fargo
California
$20K
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$23K +$15.5K +1,894 +207%
Wells Fargo
27
Wells Fargo
California
$20K -$3.74K -461 -16%
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
$14K +$13.1K +1,589 +1,432%
TRCT
29
Tower Research Capital (TRC)
New York
$8K +$891 +111 +13%
Citigroup
30
Citigroup
New York
$6K – – –
UBS Group
31
UBS Group
Switzerland
$5K +$5K +617 New
1
2